Canagliflozin-based Environmental Monitoring and Remediation Systems

Publication ID: 24-11857559_0007_PTD
Published: October 28, 2025
Category:New Applications & Use Cases

Legal Citation

pr1or.art Inc., “Canagliflozin-based Environmental Monitoring and Remediation Systems,” Published Technical Disclosure No. 24-11857559_0007_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857559_0007_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,559.

Summary of the Inventive Concept

The present inventive concept relates to novel applications of Canagliflozin in environmental monitoring and remediation, leveraging its glucose-sensing properties to detect and mitigate pollution in various industries.

Background and Problem Solved

The original patent disclosed a pharmaceutical composition comprising Canagliflozin for treating diabetes. However, the limitations of this patent lie in its restricted scope, failing to explore the broader potential of Canagliflozin in other fields. The present inventive concept addresses this limitation by applying Canagliflozin's glucose-sensing properties to environmental monitoring and remediation, providing a novel solution to the pressing issue of pollution.

Detailed Description of the Inventive Concept

The inventive concept comprises various systems and methods utilizing Canagliflozin-based sensors, catalysts, and enzymes to monitor and control environmental pollution. For instance, Claim 1 discloses a system for monitoring glucose levels in wastewater, enabling real-time detection of pollution. Claim 2 describes a method for reducing carbon footprint in industrial processes by enhancing glucose conversion efficiency using Canagliflozin-based catalysts. Similarly, Claim 3 presents a composition for bioremediation of contaminated soil, and Claim 4 describes a device for real-time monitoring of glucose levels in fermentation processes. Claim 5 outlines a process for producing biofuels using Canagliflozin-based enzymes.

Novelty and Inventive Step

The novelty of the present inventive concept lies in its application of Canagliflozin to environmental monitoring and remediation, which is entirely distinct from its original pharmaceutical application. The inventive step resides in the recognition of Canagliflozin's glucose-sensing properties and their adaptation to address pressing environmental concerns.

Alternative Embodiments and Variations

Alternative embodiments of the inventive concept could include using Canagliflozin-based sensors for monitoring glucose levels in air or soil, or developing Canagliflozin-based bioreactors for efficient glucose conversion. Variations could also involve combining Canagliflozin with other compounds to enhance its glucose-sensing properties or exploring its potential in other industries, such as food processing or agriculture.

Potential Commercial Applications and Market

The present inventive concept has significant commercial potential in the environmental monitoring and remediation market, with potential applications in industries such as wastewater treatment, industrial processes, bioremediation, and biofuel production. The market size for environmental monitoring and remediation is projected to grow substantially in the coming years, driven by increasing concerns over pollution and climate change.

Field of Art

Pharmaceutical chemistry, biotechnology, and environmental monitoring technologies involving glucose-related sensing and catalytic systems

Person of Ordinary Skill (PHOSITA) Profile

A skilled practitioner with expertise in pharmaceutical formulations, enzyme technologies, and environmental sensing systems, holding at least a master's degree in chemistry, biochemistry, or chemical engineering with 3-5 years of applied research experience

Obviousness Rationale

A PHOSITA would recognize that the unique glucose-sensing properties of Canagliflozin inherently suggest broader applications beyond pharmaceutical compositions. The molecular characteristics that enable glucose transport inhibition in pharmaceutical contexts naturally translate to sensing and catalytic technologies in environmental monitoring. The PTD's variations represent predictable extensions of the source patent's fundamental molecular understanding.

Obvious Combinations & Variations

Source Patent Element
Pharmaceutical composition with amorphous Canagliflozin demonstrating glucose interaction properties
PTD Variation
Environmental sensing systems utilizing Canagliflozin's glucose detection capabilities
Obviousness Reasoning
Known molecular properties suggest predictable application in detection technologies, representing a standard design choice for adapting pharmaceutical compounds to sensing applications
Source Patent Element
Stable pharmaceutical formulation involving precise compound interactions
PTD Variation
Bioremediation compositions using Canagliflozin as a catalyst for glucose metabolism
Obviousness Reasoning
Transferring compound interaction principles from pharmaceutical to environmental contexts represents a routine scientific extension with reasonable expectation of success
Source Patent Element
Precise chemical composition involving Canagliflozin and excipients
PTD Variation
Industrial process monitoring systems incorporating Canagliflozin-based sensing elements
Obviousness Reasoning
Adapting molecular recognition properties to industrial sensing represents an obvious technological progression using known chemical engineering techniques
Source Patent Element
Glucose transport inhibition mechanism in pharmaceutical context
PTD Variation
Enzymatic biofuel production processes leveraging Canagliflozin's glucose interaction capabilities
Obviousness Reasoning
Exploiting known molecular interaction principles for alternative technological applications constitutes a standard scientific approach with predictable outcomes
Source Patent Element
Precise pharmaceutical formulation techniques
PTD Variation
Environmental monitoring device integrating Canagliflozin-based sensing components
Obviousness Reasoning
Translating precise formulation knowledge into sensor design represents a routine engineering adaptation with high predictability
35 U.S.C. § 103 Summary: Based on US Patent 11857559's comprehensive disclosure of Canagliflozin's molecular properties, a Person Having Ordinary Skill In The Art would find the environmental monitoring and remediation applications disclosed herein to be obvious variations, lacking inventive step under 35 U.S.C. ยง 103. The PTD's technical variations represent predictable extensions of the source patent's fundamental molecular characterization, employing standard scientific adaptation techniques with reasonable expectation of success.

Original Patent Information

Patent NumberUS 11,857,559
TitlePharmaceutical composition comprising Canagliflozin, process of preparation and use thereof
Assignee(s)Aurobindo Pharma Ltd